FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 01:30:39 29/05/2024 pm IST | ||
| 0.12 EUR | 0.00% |
|
| Current month | -58.62% | ||
| 1 month | -64.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 29/24/29 | 0.12 | 0.00% |
| 28/24/28 | 0.12 | -20.00% |
| 27/24/27 | 0.15 | +7.14% |
| 24/24/24 | 0.14 | -6.67% |
| 23/24/23 | 0.15 | -16.67% |
Delayed Quote Deutsche Boerse AG
Last update May 29, 2024 at 01:30 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU0HF4 |
| ISIN | DE000SU0HF43 |
| Date issued | 10/10/2023 |
| Strike | 56.67 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.31 € |
|---|---|
| Lowest since issue | 0.12 € |
| Spread | 0.01 € |
| Spread % | 7.69% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.49
USD
Average target price
53.19
USD
Spread / Average Target
+31.38%
- Stock Market
- Certificates
- Certificat
